Literature DB >> 24215859

Association of cord blood digitalis-like factor and necrotizing enterocolitis.

Steven W Graves1, Michael S Esplin2, Paula McGee3, Dwight J Rouse4, Kenneth J Leveno5, Brian M Mercer6, Jay D Iams7, Ronald J Wapner8, Yoram Sorokin9, John M Thorp10, Susan M Ramin11, Fergal D Malone12, Mary J O'Sullivan13, Alan M Peaceman14, Gary D V Hankins15, Donald J Dudley16, Steven N Caritis17.   

Abstract

OBJECTIVE: Endogenous digoxin-like factor (EDLF) has been linked to vasoconstriction, altered membrane transport, and apoptosis. Our objective was to determine whether increased EDLF in the cord sera of preterm infants was associated with an increased incidence of necrotizing enterocolitis (NEC). STUDY
DESIGN: Cord sera from pregnant women enrolled in a randomized trial of MgSO4 for fetal neuroprotection were analyzed for EDLF using a red cell Rb(+) uptake assay in which the inhibition of sodium pump-mediated Rb(+) transport was used as a functional assay of EDLF. Specimens were assayed blinded to neonatal outcome. Cases (NEC, n = 25) and controls (neonates not developing stage 2 or 3 NEC, n = 24) were matched by study center and gestational age. None of the women had preeclampsia. Cases and controls were compared using the Wilcoxon test for continuous and the Fisher exact test for categorical variables. A conditional logistic regression analysis was used to assess the odds of case vs control by EDLF level.
RESULTS: Cases and controls were not significantly different for gestational age, race, maternal steroid use, premature rupture of membranes, or MgSO4 treatment. In logistic models adjusted for treatment group, race, premature rupture of membranes, and gestational age, cord sera EDLF was significantly associated with development of NEC (P = .023).
CONCLUSION: These data demonstrated an association between cord sera EDLF and NEC.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  cord blood; digitalis-like factor; necrotizing enterocolitis; pregnancy; sodium pump

Mesh:

Substances:

Year:  2013        PMID: 24215859      PMCID: PMC4130335          DOI: 10.1016/j.ajog.2013.11.011

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

Review 1.  Na(+), K(+)-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death.

Authors:  Shan Ping Yu
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

2.  Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants.

Authors:  Ronnie Guillet; Barbara J Stoll; C Michael Cotten; Marie Gantz; Scott McDonald; W Kenneth Poole; Dale L Phelps
Journal:  Pediatrics       Date:  2006-01-03       Impact factor: 7.124

Review 3.  Endogenous sodium pump inhibition: current status and therapeutic opportunities.

Authors:  N K Hollenberg; S W Graves
Journal:  Prog Drug Res       Date:  1996

Review 4.  New concepts in necrotizing enterocolitis.

Authors:  M S Caplan; T Jilling
Journal:  Curr Opin Pediatr       Date:  2001-04       Impact factor: 2.856

5.  Annual summary of vital statistics--1998.

Authors:  B Guyer; D L Hoyert; J A Martin; S J Ventura; M F MacDorman; D M Strobino
Journal:  Pediatrics       Date:  1999-12       Impact factor: 7.124

6.  Perinatal changes in a digoxin-like immunoreactive substance.

Authors:  D W Seccombe; M R Pudek; M F Whitfield; B E Jacobson; B K Wittmann; J F King
Journal:  Pediatr Res       Date:  1984-11       Impact factor: 3.756

7.  A novel assay of cell rubidium uptake using graphite furnace atomic absorption: application to rats on a magnesium-deficient diet.

Authors:  Yueying Zhen; Kay B Franz; Steven W Graves
Journal:  J Nutr Biochem       Date:  2005-05       Impact factor: 6.048

Review 8.  Outcomes of children of extremely low birthweight and gestational age in the 1990's.

Authors:  M Hack; A A Fanaroff
Journal:  Early Hum Dev       Date:  1999-01       Impact factor: 2.079

9.  Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial.

Authors:  Garrett K Lam; Moana Hopoate-Sitake; C David Adair; Vardaman M Buckalew; Donna D Johnson; David F Lewis; Christopher J Robinson; George R Saade; Steven W Graves
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

10.  Endogenous substance in newborn infants causing false positive digoxin measurements.

Authors:  R Valdes; S W Graves; B A Brown; M Landt
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.